Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53,569,806
-
Total 13F shares
-
4,852,710
-
Share change
-
+1,781,073
-
Total reported value
-
$20,757,863
-
Price per share
-
$4.29
-
Number of holders
-
22
-
Value change
-
+$7,837,293
-
Number of buys
-
6
-
Number of sells
-
9
Institutional Holders of SOLENO THERAPEUTICS INC - Common Stock (SLNO) as of Q2 2023
As of 30 Jun 2023,
SOLENO THERAPEUTICS INC - Common Stock (SLNO) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,852,710 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Carlyle Group Inc., Nantahala Capital Management, LLC, AIGH Capital Management LLC, J. Goldman & Co LP, Worth Venture Partners, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.